Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2025-01-03T15:47:45.065Z Has data issue: false hasContentIssue false
  • English
  • Français

Amiodarone–sirolimus interaction in a neonate with tuberous sclerosis complex

Published online by Cambridge University Press:  28 July 2022

Daniel Ebrahimi-Fakhari Open the ORCID record for Daniel Ebrahimi-Fakhari [Opens in a new window] ,
Hans G. Kehl  and
Heymut Omran
Daniel Ebrahimi-Fakhari*
Affiliation:
Department of General Pediatrics, University Children’s Hospital Muenster, Muenster, Germany
Hans G. Kehl
Affiliation:
Department of Pediatric Cardiology, University Children’s Hospital Muenster, Muenster, Germany
Heymut Omran
Affiliation:
Department of General Pediatrics, University Children’s Hospital Muenster, Muenster, Germany
*
Author for correspondence: Dr. Daniel Ebrahimi-Fakhari, MD, Department of General Pediatrics, University Children’s Hospital Muenster, Albert-Schweitzer-Campus 1, Muenster 48149, Germany. Tel: +492518340073; Fax: +492518347765. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

Cardiac tumourinteractionmTOR inhibitorrapamycinrhabdomyomatuberous sclerosis complexTSC
Type
Brief Report
Information
Cardiology in the Young , Volume 33 , Issue 4 , April 2023 , pp. 655 - 656
Check for updates
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ebrahimi-Fakhari, D, Mann, LL, Poryo, M, et al. Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study. Orphanet J Rare Dis 2018; 13: 117.CrossRefGoogle ScholarPubMed
Nalli, N, Stewart-Teixeira, L, Dipchand, AI. Amiodarone-sirolimus/tacrolimus interaction in a pediatric heart transplant patient. Pediatr Transplant 2006; 10: 736–739.CrossRefGoogle Scholar
Saffari, A, Brosse, I, Wiemer-Kruel, A, et al. Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study. Orphanet J Rare Dis 2019; 14: 96.CrossRefGoogle ScholarPubMed